Pitchayathida Mee-Udorn

In Silico and In Vitro Potential of FDA-Approved Drugs for Antimalarial Drug Repurposing against Plasmodium Serine Hydroxymethyltransferases

T. Rungrotmongkol, S. Maenpuen, R. Tinikul, 2023, ACS omega.

Mangiferin is a new potential antimalarial and anticancer drug for targeting serine hydroxymethyltransferase.

T. Rungrotmongkol, S. Maenpuen, C. Pinthong, 2023, Archives of biochemistry and biophysics.

A flap motif in human serine hydroxymethyltransferase is important for structural stabilization, ligand binding, and control of product release

T. Rungrotmongkol, S. Maenpuen, P. Chaiyen, 2019, The Journal of Biological Chemistry.